A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ
Metrics: PDF 2572 views | HTML 2668 views | ?
Guosheng Tan1,*, Xinping Cao2,*, Qiangsheng Dai3,*, Bing Zhang4, Jianwen Huang5, Shiqiu Xiong6, Yong yu Zhang1, Wei Chen1, Jianyong Yang1, Heping Li1,3
1Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China
3Department of Medical Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
4Department of Nuclear Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
5Department of Radiation Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
6Department of Biochemistry, University of Leicester, Leicester, UK
*These authors have contributed equally to this work
Heping Li, e-mail: [email protected]
Jianyong Yang, e-mail: [email protected]
Keywords: miR-129-5p, YAP, TAZ, cell proliferation, survival
Received: November 30, 2014 Accepted: January 28, 2015 Published: April 07, 2015
Transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are key oncogenes in mammalian cells. Activities of YAP and TAZ are largely restricted by the Hippo tumor suppressor pathway through phosphorylation-ubiquitination mechanisms. The involvement of microRNA in cancer progression has recently been reported, though whether they have a role in activating YAP and TAZ in human cancer cells remains unclear. Here, we report a microRNA, miR-129-5p, directly represses YAP and TAZ expression, leading to the inactivation of TEA domain (TEAD) transcription, and the downregulation of Hippo downstream genes, connective tissue growth factor (CTGF) and Cyclin A. Furthermore, we reveal miR-129-5p inhibits ovarian cancer cell proliferation, survival and tumorigenicity, and that downregulation of miR-129-5p in ovarian cancer cells highly correlates with malignant progression and poor survival. Hence, we demonstrate a novel mechanism for YAP and TAZ activation in cancers, indicating not only a potentially pivotal role for miR-129-5p in the progression of ovarian cancer, but also offering new therapeutic strategies to circumvent the disease.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.